" /> Anti-PSMA Antibody-drug Conjugate ARX517 - CISMeF





Preferred Label : Anti-PSMA Antibody-drug Conjugate ARX517;

NCIt synonyms : Anti-PSMA ADC ARX517; ADC ARX517; Anti-PSMA/AS269 ADC ARX517;

NCIt definition : An antibody-drug conjugate (ADC) containing a humanized immunoglobulin G1 kappa (IgG1k) monoclonal antibody directed against prostate-specific membrane antigen (PSMA) and site-specifically conjugated to two of the microtubule-disrupting toxin amberstatin (AS269), with potential antineoplastic activity. Upon administration of anti-PSMA ADC ARX517, the monoclonal antibody moiety selectively binds to PSMA, a protein which is abundantly expressed on the surface of metastatic and hormone-refractory prostate cancer cells. Upon internalization, amberstatin binds to tubulin and inhibits its polymerization, resulting in G2/M phase arrest and tumor cell apoptosis. The site-specific conjugation of the cytotoxic agent to the antibody improves the biophysical properties of ARX517, increases payload stability and optimizes its efficacy.;

Molecule name : ARX 517; ARX517;

NCI Metathesaurus CUI : CL1647858;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.